Cue Biopharma, Inc. (CUE) Operating margin 2018–2025
Cue Biopharma, Inc. (CUE) operating margin by fiscal year — reported operating income divided by reported revenue.
-96.7%FY2025 · since FY2018: -3386.7% → -96.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -96.7% | +350.2 pp |
| FY2024 | -446.9% | +503.0 pp |
| FY2023 | -949.9% | +3325.2 pp |
| FY2022 | -4275.1% | -3982.5 pp |
| FY2021 | -292.6% | +1135.4 pp |
| FY2020 | -1428.0% | -364.8 pp |
| FY2019 | -1063.2% | +2323.5 pp |
| FY2018 | -3386.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice